Reply to Sun : circGASP: A New Clinical Biomarker for Idiopathic Pulmonary Hypertension?
作者信息
Sun Yuan-Yuan, Wang Lan, Liu Jin-Ming, Yuan Ping
机构信息
Shanghai Pulmonary Hospital Affiliated to Tongji University Shanghai, China.
出版信息
Am J Respir Crit Care Med. 2022 Jan 15;205(2):254. doi: 10.1164/rccm.202108-1905LE.
Abstract
摘要
相似文献
1
Reply to Sun : circGASP: A New Clinical Biomarker for Idiopathic Pulmonary Hypertension?回复孙：环状GASP：特发性肺动脉高压的一种新的临床生物标志物？
Am J Respir Crit Care Med. 2022 Jan 15;205(2):254. doi: 10.1164/rccm.202108-1905LE.
2
circGSAP: A New Clinical Biomarker for Idiopathic Pulmonary Hypertension?环状GSAP：特发性肺动脉高压的一种新的临床生物标志物？
Am J Respir Crit Care Med. 2022 Jan 15;205(2):252-253. doi: 10.1164/rccm.202108-1868LE.
3
Questions Regarding the Value of CCL21 as a Potential Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis: Comment on the Article by Hoffmann-Vold et al.关于CCL21作为系统性硬化症中肺动脉高压潜在生物标志物价值的问题：对霍夫曼 - 沃尔德等人文章的评论
Arthritis Rheumatol. 2019 Apr;71(4):653-654. doi: 10.1002/art.40743. Epub 2019 Mar 1.
4
Insufficient Evidence to Consider CCL21 a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis: Comment on the Article by Hoffmann-Vold et al.证据不足，无法将CCL21视为系统性硬化症中肺动脉高压的潜在血清生物标志物：对Hoffmann-Vold等人文章的评论
Arthritis Rheumatol. 2019 Apr;71(4):654-655. doi: 10.1002/art.40819. Epub 2019 Mar 2.
5
Reply to Ning : More Insights into the Association between RVX-208 and Pulmonary Arterial Hypertension.致宁的回复：对RVX-208与肺动脉高压之间关联的更多见解
Am J Respir Crit Care Med. 2020 Feb 1;201(3):389-391. doi: 10.1164/rccm.201909-1800LE.
6
Reply to Weatherald : Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?对韦瑟罗尔德的回复：肺动脉高压中的肺血管阻力：关键因素？
Am J Respir Crit Care Med. 2021 Feb 15;203(4):525-526. doi: 10.1164/rccm.202010-3834LE.
7
Reply to Chen : BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?对陈的回复：BET信号传导：肺动脉高压的新型治疗靶点？
Am J Respir Crit Care Med. 2020 May 15;201(10):1313-1314. doi: 10.1164/rccm.202001-0059LE.
8
Signals and signposts: Biomarkers in IPF and PAH at the crossroads of clinical relevance.信号与路标：特发性肺纤维化和肺动脉高压中处于临床相关性十字路口的生物标志物
Respirology. 2019 Nov;24(11):1044-1045. doi: 10.1111/resp.13694. Epub 2019 Sep 5.
9
Reply.
Arthritis Rheumatol. 2019 Apr;71(4):655-656. doi: 10.1002/art.40816. Epub 2019 Mar 2.
10
[Diagnosis of idiopathic pulmonary arterial hypertension by "3P" algorithm].[采用“3P”算法诊断特发性肺动脉高压]
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jul 24;48(7):621-625. doi: 10.3760/cma.j.cn112148-20200228-00140.
引用本文的文献
1
CircGSAP alleviates pulmonary microvascular endothelial cells dysfunction in pulmonary hypertension via regulating miR-27a-3p/BMPR2 axis.环状 GSAP 通过调控 miR-27a-3p/BMPR2 轴缓解肺动脉高压肺微血管内皮细胞功能障碍。
Respir Res. 2022 Nov 19;23(1):322. doi: 10.1186/s12931-022-02248-7.
本文引用的文献
1
Nuclear export and translation of circular repeat-containing intronic RNA in C9ORF72-ALS/FTD.C9ORF72-ALS/FTD 中含有环状重复的内含子 RNA 的核输出和翻译。
Nat Commun. 2021 Aug 13;12(1):4908. doi: 10.1038/s41467-021-25082-9.
2
Impact of circGSAP in Peripheral Blood Mononuclear Cells on Idiopathic Pulmonary Arterial Hypertension.外周血单个核细胞中环GSAP对特发性肺动脉高压的影响
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1579-1583. doi: 10.1164/rccm.202005-2052LE.
3
Circ- Serves as an Sponge to Regulate Myo10 (Myosin 10) and Promote Pulmonary Artery Smooth Muscle Proliferation.环状 RNA 作为海绵体调节肌球蛋白 10 并促进肺动脉平滑肌增殖。
Hypertension. 2020 Mar;75(3):668-679. doi: 10.1161/HYPERTENSIONAHA.119.13715. Epub 2020 Feb 3.
4
Molecular Mechanisms Driving mRNA Degradation by mA Modification.mA 修饰调控 mRNA 降解的分子机制。
Trends Genet. 2020 Mar;36(3):177-188. doi: 10.1016/j.tig.2019.12.007. Epub 2020 Jan 18.
5
The biogenesis, biology and characterization of circular RNAs.环状 RNA 的生物发生、生物学和特征。
Nat Rev Genet. 2019 Nov;20(11):675-691. doi: 10.1038/s41576-019-0158-7. Epub 2019 Aug 8.
6
Circular RNA Expression: Its Potential Regulation and Function.环状RNA表达：其潜在调控与功能
Trends Genet. 2016 May;32(5):309-316. doi: 10.1016/j.tig.2016.03.002. Epub 2016 Apr 2.
Zotero 插件